GE HealthCare Technologies (NASDAQ:GEHC) Issues Quarterly Earnings Results, Beats Estimates By $0.09 EPS

GE HealthCare Technologies (NASDAQ:GEHC) announced its quarterly earnings data on Wednesday. The company reported $1.13 EPS for the quarter, topping analysts’ consensus estimates of $1.04 by $0.09, FiscalAI reports. The firm had revenue of $5.29 billion during the quarter, compared to analyst estimates of $5.26 billion. GE HealthCare Technologies had a return on equity of 20.46% and a net margin of 9.10%.The company’s revenue was up 5.8% on a year-over-year basis. During the same period last year, the company earned $1.06 earnings per share.

Here are the key takeaways from GE HealthCare Technologies’ conference call:

• Orders rose 11.1% year over year, with a record 1.15x book-to-bill and backlog of $23.9 billion, up $2.6 billion from a year ago. Management said the strength was broad-based and not driven by one-time deals.
• Pharmaceutical Diagnostics delivered 14.6% organic revenue growth, supported by contrast media and radiopharmaceuticals. Flyrcado doses increased approximately 40% from April levels to 545 for the week ending July 24, and GE HealthCare maintained its target of at least $500 million in annual Flyrcado revenue by 2028.
• Patient Care Solutions revenue declined 13.5% and the segment reported negative EBIT due to fulfillment and supply-chain challenges. Management expects sequential improvement in the second half while reviewing strategic alternatives, including continued ownership or a potential sale.
• GE HealthCare maintained its full-year outlook of 3%–4% organic sales growth, 15.4%–15.7% adjusted EBIT margin, adjusted EPS of $4.80–$5.00, and approximately $1.6 billion in free cash flow. Second-quarter adjusted EBIT margin fell 40 basis points to 14.2% as PCS weakness and inflation offset volume growth and pricing actions.
• CFO Jay Saccaro announced his departure, with Controller and Chief Accounting Officer George Newcomb serving as interim CFO while the company begins a search for a permanent successor.

GE HealthCare Technologies Trading Up 11.0%

Shares of NASDAQ GEHC traded up $7.05 during midday trading on Wednesday, reaching $71.16. 9,394,056 shares of the stock were exchanged, compared to its average volume of 4,542,288. The business has a 50-day simple moving average of $63.68 and a two-hundred day simple moving average of $70.80. The company has a market capitalization of $32.37 billion, a price-to-earnings ratio of 16.99, a P/E/G ratio of 1.66 and a beta of 0.72. GE HealthCare Technologies has a 12 month low of $58.75 and a 12 month high of $89.77. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, August 14th. Shareholders of record on Friday, July 24th will be issued a $0.035 dividend. The ex-dividend date is Friday, July 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.35%.

Key GE HealthCare Technologies News

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: GEHC beat earnings and revenue estimates. Adjusted earnings were $1.13 per share, above the $1.04 consensus and up from $1.06 a year earlier. Revenue rose approximately 5.7% to $5.29 billion, slightly exceeding the $5.26 billion estimate. GE HealthCare Technologies Beats Q2 Earnings and Revenue Estimates
• Positive Sentiment: Orders and backlog reached records. Orders increased 11.1%, with growth reported across every segment, while backlog climbed to $23.9 billion. The results suggest solid demand and improved visibility for future revenue. GEHC Q2 Earnings and Revenues Beat Estimates
• Positive Sentiment: Imaging demand supported profitability. Strong demand for diagnostic and imaging devices helped drive the quarterly performance. Refunds related to U.S. tariffs also benefited results. GE HealthCare Beats Quarterly Profit Estimates
• Positive Sentiment: Options activity reflected bullish positioning. Traders purchased 8,956 call options, about 45% above average call volume, indicating increased speculative interest following the earnings report.
• Neutral Sentiment: Management said Patient Care Solutions remains a focus as it works to restore growth and profitability, and the company is reviewing strategies for that business. This creates a continuing execution risk despite the strong consolidated results. GE HealthCare Reports Second Quarter 2026 Financial Results

Analyst Upgrades and Downgrades

Several research analysts have recently issued reports on the stock. Royal Bank Of Canada assumed coverage on shares of GE HealthCare Technologies in a research note on Tuesday, June 23rd. They issued an “outperform” rating and a $80.00 target price on the stock. Mizuho reduced their price objective on shares of GE HealthCare Technologies from $90.00 to $80.00 in a research note on Thursday, April 30th. Wells Fargo & Company lowered their target price on shares of GE HealthCare Technologies from $97.00 to $75.00 and set an “overweight” rating for the company in a report on Thursday, April 30th. Oppenheimer reissued an “outperform” rating and issued a $85.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, April 30th. Finally, Evercore set a $80.00 price target on GE HealthCare Technologies in a research report on Thursday, April 30th. Ten investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $76.41.

Insiders Place Their Bets

In other news, CEO Peter J. Arduini acquired 4,169 shares of the stock in a transaction that occurred on Thursday, April 30th. The stock was acquired at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the transaction, the chief executive officer directly owned 259,424 shares in the company, valued at approximately $15,544,686.08. This represents a 1.63% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this link. Also, Director Rodney F. Hochman acquired 1,618 shares of the company’s stock in a transaction that occurred on Tuesday, May 12th. The shares were acquired at an average cost of $62.03 per share, for a total transaction of $100,364.54. Following the purchase, the director directly owned 1,618 shares in the company, valued at $100,364.54. This trade represents a ? increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have purchased 21,847 shares of company stock worth $1,361,355 over the last 90 days. 0.36% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of GEHC. Transamerica Financial Advisors LLC boosted its holdings in shares of GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock valued at $28,000 after buying an additional 262 shares during the period. Caitong International Asset Management Co. Ltd acquired a new position in GE HealthCare Technologies in the 4th quarter worth $34,000. Zions Bancorporation National Association UT boosted its stake in GE HealthCare Technologies by 125.1% in the 4th quarter. Zions Bancorporation National Association UT now owns 412 shares of the company’s stock worth $34,000 after purchasing an additional 229 shares during the period. Miller Capital Partners Inc. bought a new position in GE HealthCare Technologies during the 4th quarter worth about $38,000. Finally, Palisade Asset Management LLC acquired a new stake in shares of GE HealthCare Technologies in the 3rd quarter valued at about $41,000. Institutional investors own 82.06% of the company’s stock.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.